Abstract
Cancer predisposition syndromes are associated with an increased risk of developing primary malignancies. Here we discuss those which are associated with an increased risk of tumors of the central nervous system (CNS) and gastrointestinal (GI) tract. These can be grouped into those in which the CNS tumors predominate versus those in which the GI cancers predominate. The former include constitutional mismatch repair deficiency (CMMRD) syndrome, Li–Fraumeni syndrome (LFS), and Cowden syndrome (CS) while the latter include familial adenomatosis polyposis 1 (FAP1), Lynch syndrome and polymerase proofreading-associated polyposis syndrome (PPAP). Tumor specificity does exist as medulloblastoma occur in FAP, LFS and CMMRD while glioma are most commonly seen in all replication repair-deficient genes and LFS. Choroid plexus carcinoma is strictly observed in LFS while Cowden syndrome patients develop Lhermitte Duclos disease or meningioma. In each syndrome, specific types of low-grade and high-grade gastrointestinal cancers can occur, but these will be discussed elsewhere. Underlying cancer predisposition syndromes are important to consider when faced with brain tumors, particularly in the pediatric and young adult age groups, as identification of an underlying germ line mutation may change the upfront management of the patient and has implications for future cancer surveillance for both the patient and potentially affected family members. Considerations of family history, presence of skin lesions and consanguinity provide valuable information in identifying patients at potential increased risk.
Similar content being viewed by others
References
Abedalthagafi M (2018) Constitutional mismatch repair-deficiency: current problems and emerging therapeutic strategies. Oncotarget 9:35458–35469. https://doi.org/10.18632/oncotarget.26249
Abel TW, Baker SJ, Fraser MM, Tihan T, Nelson JS, Yachnis AT et al (2005) Lhermitte-Duclos disease: a report of 31 cases with immunohistochemical analysis of the PTEN/AKT/mTOR pathway. J Neuropathol Exp Neurol 64:341–349. https://doi.org/10.1093/jnen/64.4.341
Aihara H, Tajiri H, Schneider M, Charton J-P, Neuhaus H (2014) Colon Capsule endoscopy in screening and surveillance for polyps and cancers. In: Keuchel M, Hagenmüller F, Tajiri H (eds) Video capsule endoscopy: a reference guide and atlas. Springer, Berlin, Heidelberg, pp 495–505
Alexandrov LB, Kim J, Haradhvala NJ, Huang MN, Ng AW, Boot A et al (2018) The Repertoire of Mutational Signatures in Human Cancer. Biorxiv. https://doi.org/10.1101/322859
Alexandrov LB, Nik-Zainal S, Wedge DC, Aparicio SAJR, Behjati S, Biankin AV et al (2013) Signatures of mutational processes in human cancer. Nature 500:415–421. https://doi.org/10.1038/nature12477
AlSalameh A, François P, Giraud S, Calender A, Bergemer-Fouquet AM, de Calan L et al (2010) Intracranial ependymoma associated with multiple endocrine neoplasia type 1. J Endocrinol Invest 33:353–356. https://doi.org/10.1007/BF03346599
Amayiri N, Tabori U, Campbell B, Bakry D, Aronson M, Durno C et al (2016) High frequency of mismatch repair deficiency among pediatric high grade gliomas in Jordan. Int J Cancer 138:380–385. https://doi.org/10.1002/ijc.29724
Bakry D, Aronson M, Durno C, Rimawi H, Farah R, Alharbi QK et al (1990) (2014) Genetic and clinical determinants of constitutional mismatch repair deficiency syndrome: report from the constitutional mismatch repair deficiency consortium. Eur J Cancer Oxf Engl 50:987–996. https://doi.org/10.1016/j.ejca.2013.12.005
Ballinger ML, Mitchell G, Thomas DM (2015) Surveillance recommendations for patients with germline TP53 mutations. Curr Opin Oncol 27:332–337. https://doi.org/10.1097/CCO.0000000000000200
Barel D, Avigad S, Mor C, Fogel M, Cohen IJ, Zaizov R (1998) A Novel Germ-line mutation in the noncoding region of the p53 gene in a Li–Fraumeni family. Cancer Genet Cytogenet 103:1–6. https://doi.org/10.1016/S0165-4608(97)00258-6
Blumenthal GM, Dennis PA (2008) PTEN hamartoma tumor syndromes. Eur J Hum Genet EJHG 16:1289–1300. https://doi.org/10.1038/ejhg.2008.162
Bodo S, Colas C, Buhard O, Collura A, Tinat J, Lavoine N et al (2015) Diagnosis of constitutional mismatch repair-deficiency syndrome based on microsatellite instability and lymphocyte tolerance to methylating agents. Gastroenterology 149:1017–1029.e3. https://doi.org/10.1053/j.gastro.2015.06.013
Bouffet E, Larouche V, Campbell BB, Merico D, Borja RD, Aronson M et al (2016) Immune checkpoint inhibition for hypermutant glioblastoma multiforme resulting from germline biallelic mismatch repair deficiency. J Clin Oncol 34:2206–2211. https://doi.org/10.1200/JCO.2016.66.6552
Buchanan DD, Stewart JR, Clendenning M, Rosty C, Mahmood K, Pope BJ et al (2018) Risk of colorectal cancer for carriers of a germ-line mutation in POLE or POLD1. Genet Med 20:890. https://doi.org/10.1038/gim.2017.185
Burt RW, Cannon JA, David DS, Early DS, Ford JM, Giardiello FM et al (2013) Colorectal cancer screening. J Natl Compr Canc Netw 11:1538–1575. https://doi.org/10.6004/jnccn.2013.0180
Bussey HJR (1975) Familial polyposis coli: family studies, histopathology, differential diagnosis, and results of treatment. Johns Hopkins University Press, Baltimore
Campbell BB, Light N, Fabrizio D, Zatzman M, Fuligni F, de Borja R et al (2017) Comprehensive analysis of hypermutation in human cancer. Cell 171:1042–1056.e10. https://doi.org/10.1016/j.cell.2017.09.048
Chang DK, Ricciardiello L, Goel A, Chang CL, Boland CR (2000) Steady-state regulation of the human DNA mismatch repair system. J Biol Chem 275:18424–18431. https://doi.org/10.1074/jbc.M001140200
Chapelle A (2005) The incidence of Lynch syndrome. Fam Cancer 4:233–237. https://doi.org/10.1007/s10689-004-5811-3
Chen S, Wang W, Lee S, Nafa K, Lee J, Romans K et al (2006) Prediction of germline mutations and cancer risk in the Lynch syndrome. JAMA 296:1479–1487. https://doi.org/10.1001/jama.296.12.1479
Cohen SA, Leininger A (2014) The genetic basis of Lynch syndrome and its implications for clinical practice and risk management. Appl Clin Genet 7:147–158. https://doi.org/10.2147/TACG.S51483
Cuevas-Ocampo AK, Bollen AW, Goode B, Pajtler KW, Chavez L, Sharma T et al (2017) Genetic confirmation that ependymoma can arise as part of multiple endocrine neoplasia type 1 (MEN1) syndrome. Acta Neuropathol (Berl) 133:661–663. https://doi.org/10.1007/s00401-017-1689-7
Daly MB, Pilarski R, Berry M, Buys SS, Farmer M, Friedman S et al (2017) NCCN guidelines insights: genetic/familial high-risk assessment: breast and ovarian, version 2.2017. J Natl Compr Cancer Netw JNCCN 15:9–20
Devroede G, Lemieux B, Massé S, Lamarche J, Herman PS (1988) Colonic hamartomas in tuberous sclerosis. Gastroenterology 94:182–188. https://doi.org/10.1016/0016-5085(88)90628-2
Durno CA, Aronson M, Tabori U, Malkin D, Gallinger S, Chan HSL (2012) Oncologic surveillance for subjects with biallelic mismatch repair gene mutations: 10 year follow-up of a kindred. Pediatr Blood Cancer 59:652–656. https://doi.org/10.1002/pbc.24019
Durno CA, Sherman PM, Aronson M, Malkin D, Hawkins C, Bakry D et al (2015) Phenotypic and genotypic characterisation of biallelic mismatch repair deficiency (BMMR-D) syndrome. Eur J Cancer Oxf Engl 51:977–983. https://doi.org/10.1016/j.ejca.2015.02.008
Elsayed FA, Kets CM, Ruano D, van den Akker B, Mensenkamp AR, Schrumpf M et al (2015) Germline variants in POLE are associated with early onset mismatch repair deficient colorectal cancer. Eur J Hum Genet 23:1080–1084. https://doi.org/10.1038/ejhg.2014.242
Erson-Omay EZ, Çağlayan AO, Schultz N, Weinhold N, Omay SB, Özduman K et al (2015) Somatic POLE mutations cause an ultramutated giant cell high-grade glioma subtype with better prognosis. Neuro-Oncol 17:1356–1364. https://doi.org/10.1093/neuonc/nov027
Funayama T, Sakane M, Yoshizawa T, Takeuchi Y, Ochiai N (2013) Tanycytic ependymoma of the filum terminale associated with multiple endocrine neoplasia type 1: first reported case. Spine J 13:e49–e54. https://doi.org/10.1016/j.spinee.2013.02.066
Gardner EJ, Richards RC (1953) Multiple cutaneous and subcutaneous lesions occurring simultaneously with hereditary polyposis and osteomatosis. Am J Hum Genet 5:139–147
Guha A, Glowacka D, Carroll R, Dashner K, Black PM, Stiles CD (1995) Expression of platelet derived growth factor and platelet derived growth factor receptor mRNA in a glioblastoma from a patient with Li–Fraumeni syndrome. J Neurol Neurosurg Psychiatry 58:711–714
Gylling AHS, Nieminen TT, Abdel-Rahman WM, Nuorva K, Juhola M, Joensuu EI et al (2008) Differential cancer predisposition in Lynch syndrome: insights from molecular analysis of brain and urinary tract tumors. Carcinogenesis 29:1351–1359. https://doi.org/10.1093/carcin/bgn133
Hamilton SR, Liu B, Parsons RE, Papadopoulos N, Jen J, Powell SM et al (1995) The molecular basis of Turcot’s syndrome. N Engl J Med 332:839–847. https://doi.org/10.1056/NEJM199503303321302
Heald B, Mester J, Rybicki L, Orloff MS, Burke CA, Eng C (2010) Frequent gastrointestinal polyps and colorectal adenocarcinomas in a prospective series of PTEN mutation carriers. Gastroenterology 139:1927–1933. https://doi.org/10.1053/j.gastro.2010.06.061
Hisada M, Garber JE, Fung CY, Fraumeni JF, Li FP (1998) Multiple primary cancers in families with Li–Fraumeni syndrome. J Natl Cancer Inst 90:606–611. https://doi.org/10.1093/jnci/90.8.606
Hobert JA, Eng C (2009) PTEN hamartoma tumor syndrome: an overview. Genet Med 11:687–694. https://doi.org/10.1097/GIM.0b013e3181ac9aea
Jasperson KW, Patel SG, Ahnen DJ (1993) APC-associated polyposis conditions. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJ, Stephens K, Amemiya A (eds) GeneReviews®. University of Washington Seattle, Seattle.
Kempers MJ, Kuiper RP, Ockeloen CW, Chappuis PO, Hutter P, Rahner N et al (2011) Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort study. Lancet Oncol 12:49–55. https://doi.org/10.1016/S1470-2045(10)70265-5
Kovacs ME, Papp J, Szentirmay Z, Otto S, Olah E (2009) Deletions removing the last exon of TACSTD1 constitute a distinct class of mutations predisposing to Lynch syndrome. Hum Mutat 30:197–203. https://doi.org/10.1002/humu.20942
Krishnamurthy N, Kurzrock R (2018) Targeting the Wnt/beta-catenin pathway in cancer: update on effectors and inhibitors. Cancer Treat Rev 62:50–60. https://doi.org/10.1016/j.ctrv.2017.11.002
Krutilkova V, Trkova M, Fleitz J, Gregor V, Novotna K, Krepelova A et al (2005) Identification of five new families strengthens the link between childhood choroid plexus carcinoma and germline TP53 mutations. Eur J Cancer 41:1597–1603. https://doi.org/10.1016/j.ejca.2005.01.026
Lachlan KL, Lucassen AM, Bunyan D, Temple IK (2007) Cowden syndrome and Bannayan Riley Ruvalcaba syndrome represent one condition with variable expression and age-related penetrance: results of a clinical study of PTEN mutation carriers. J Med Genet 44:579–585. https://doi.org/10.1136/jmg.2007.049981
Lavoine N, Colas C, Muleris M, Bodo S, Duval A, Entz-Werle N et al (2015) Constitutional mismatch repair deficiency syndrome: clinical description in a French cohort. J Med Genet 52:770–778. https://doi.org/10.1136/jmedgenet-2015-103299
Le DT, Uram JN, Wang H, Bartlett BR, Kemberling H, Eyring AD et al (2015) PD-1 blockade in tumors with mismatch-repair deficiency. N Engl J Med 372:2509–2520. https://doi.org/10.1056/NEJMoa1500596
Leoz ML, Carballal S, Moreira L, Ocaña T, Balaguer F (2015) The genetic basis of familial adenomatous polyposis and its implications for clinical practice and risk management. Appl Clin Genet 8:95–107. https://doi.org/10.2147/TACG.S51484
Li FP (1969) Soft-tissue sarcomas, breast cancer, and other neoplasms: a familial syndrome? Ann Intern Med 71:747. https://doi.org/10.7326/0003-4819-71-4-747
Li FP, Fraumeni JF, Mulvihill JJ, Blattner WA, Dreyfus MG, Tucker MA et al (1988) A cancer family syndrome in 24 kindreds. Cancer Res 48:5358–5362
Li J, Woods SL, Healey S, Beesley J, Chen X, Lee JS et al (2016) Point mutations in exon 1B of APC reveal gastric adenocarcinoma and proximal polyposis of the stomach as a familial adenomatous polyposis variant. Am J Hum Genet 98:830–842. https://doi.org/10.1016/j.ajhg.2016.03.001
Liaw D, Marsh DJ, Li J, Dahia PLM, Wang SI, Zheng Z et al (1997) Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet 16:64. https://doi.org/10.1038/ng0597-64
Lindor NM, McMaster ML, Lindor CJ, Greene MH (2008) Concise handbook of familial cancer susceptibility syndromes—second edition. J Natl Cancer Inst Monogr. https://doi.org/10.1093/jncimonographs/lgn001
Lloyd KM (1963) Cowden’s disease: a possible new symptom complex with multiple system involvement. Ann Intern Med 58:136. https://doi.org/10.7326/0003-4819-58-1-136
Lynch ED, Ostermeyer EA, Lee MK, Arena JF, Ji H, Dann J et al (1997) Inherited mutations in PTEN that are associated with breast cancer, Cowden disease, and juvenile polyposis. Am J Hum Genet 61:1254–1260. https://doi.org/10.1086/301639
Malkin D, Jolly KW, Barbier N, Look AT, Friend SH, Gebhardt MC et al (1992) Germline mutations of the p53 tumor-suppressor gene in children and young adults with second malignant neoplasms. N Engl J Med 326:1309–1315. https://doi.org/10.1056/NEJM199205143262002
Marsh DJ, Trahair TN, Martin JL, Chee WY, Walker J, Kirk EP et al (2008) Rapamycin treatment for a child with germline PTEN mutation. Nat Clin Pract Oncol 5:357–361. https://doi.org/10.1038/ncponc1112
Menko FH, Kaspers GL, Meijer GA, Claes K, van Hagen JM, Gille JJP (2004) A homozygous MSH6 mutation in a child with Café-au-Lait spots, oligodendroglioma and rectal cancer. Fam Cancer 3:123–127. https://doi.org/10.1023/B:FAME.0000039893.19289.18
Miyaki M, Nishio J, Konishi M, Kikuchi-Yanoshita R, Tanaka K, Muraoka M et al (1997) Drastic genetic instability of tumors and normal tissues in Turcot syndrome. Oncogene 15:2877–2881. https://doi.org/10.1038/sj.onc.1201668
NCCN (2018) National Comprehensive Cancer Network guidelines for colorectal cancer screening. National Comprehensive Cancer Network. https://www.nccn.org/professionals/physician_gls/pdf/colorectal_screening.pdf. Accessed 4 June 2019
Nelen MR, Padberg GW, Peeters EA, Lin AY, van den Helm B, Frants RR et al (1996) Localization of the gene for Cowden disease to chromosome 10q22–23. Nat Genet 13:114–116. https://doi.org/10.1038/ng0596-114
Nicolaides NC, Papadopoulos N, Liu B, Weit Y-F, Carter KC, Ruben SM et al (1994) Mutations of two P/WS homologues in hereditary nonpolyposis colon cancer. Nature 371:75–80. https://doi.org/10.1038/371075a0
Northcott PA, Jones DT, Kool M, Robinson GW, Gilbertson RJ, Cho Y-J et al (2012) Medulloblastomics: the end of the beginning. Nat Rev Cancer 12:818–834. https://doi.org/10.1038/nrc3410
Olivier M, Goldgar DE, Sodha N, Ohgaki H, Kleihues P, Hainaut P et al (2003) Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype. Cancer Res 63:6643–6650
Ou J, Rasmussen M, Westers H, Andersen SD, Jager PO, Kooi KA et al (2009) Biochemical characterization of MLH3 missense mutations does not reveal an apparent role of MLH3 in Lynch syndrome. Genes Chromosomes Cancer 48:340–350. https://doi.org/10.1002/gcc.20644
Palles C, Cazier J-B, Howarth KM, Domingo E, Jones AM, Broderick P et al (2013) Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas. Nat Genet 45:136–144. https://doi.org/10.1038/ng.2503
Papadopoulos N, Lindblom A (1997) Molecular basis of HNPCC: mutations of MMR genes. Hum Mutat 10:89–99. https://doi.org/10.1002/(SICI)1098-1004(1997)10:2%3c89:AID-HUMU1%3e3.0.CO;2-H
Pietsch T, Haberler C (2016) Update on the integrated histopathological and genetic classification of medulloblastoma—a practical diagnostic guideline. Clin Neuropathol 35:344–352. https://doi.org/10.5414/NP300999
Rao TP, Kühl M (2010) An updated overview on wnt signaling pathways. Circ Res 106:1798–1806. https://doi.org/10.1161/CIRCRESAHA.110.219840
Rausch T, Jones DTW, Zapatka M, Stütz AM, Zichner T, Weischenfeldt J et al (2012) Genome sequencing of pediatric medulloblastoma links catastrophic DNA rearrangements with TP53 mutations. Cell 148:59–71. https://doi.org/10.1016/j.cell.2011.12.013
Rieske P, Zakrzewska M, Biernat W, Bartkowiak J, Zimmermann A, Piotr-Liberski P (2005) Atypical molecular background of glioblastoma and meningioma developed in a patient with Li–Fraumeni syndrome. J Neurooncol 71:27–30. https://doi.org/10.1007/s11060-004-9181-3
Rosner G, Elya R, Bercovich D, Santo E, Halpern Z, Kariv R (2015) Mutations in DNA Polymerase Genes (POLD1 and POLE) in Individuals having early-onset colorectal cancer and/or multiple adenomas. Gastroenterology 148:S-S63. https://doi.org/10.1016/S0016-5085(15)30220-1
Schwitalle Y, Kloor M, Eiermann S, Linnebacher M, Kienle P, Knaebel HP et al (2008) Immune response against frameshift-induced neopeptides in HNPCC patients and healthy HNPCC mutation carriers. Gastroenterology 134:988–997. https://doi.org/10.1053/j.gastro.2008.01.015
Shaco-Levy R, Jasperson KW, Martin K, Samadder NJ, Burt RW, Ying J et al (2017) Gastrointestinal polyposis in Cowden syndrome. J Clin Gastroenterol 51:e60–e67. https://doi.org/10.1097/MCG.0000000000000703
Shlien A, Campbell BB, de Borja R, Alexandrov LB, Merico D, Wedge D et al (2015) Combined hereditary and somatic mutations of replication error repair genes result in rapid onset of ultra-hypermutated cancers. Nat Genet 47:257–262. https://doi.org/10.1038/ng.3202
Shuen AY, Lanni S, Panigrahi GB, Edwards M, Yu L, Campbell BB et al (2019) Functional repair assay for the diagnosis of constitutional mismatch repair deficiency from non-neoplastic tissue. J Clin Oncol 37:461–470. https://doi.org/10.1200/JCO.18.00474
Sinicrope FA, Sargent DJ (2012) Molecular pathways: microsatellite instability in colorectal cancer: prognostic, predictive, and therapeutic implications. Clin Cancer Res 18:1506–1512. https://doi.org/10.1158/1078-0432.CCR-11-1469
South CD, Hampel H, Comeras I, Westman JA, Frankel WL, de la Chapelle A (2008) The frequency of Muir–Torre syndrome among Lynch syndrome families. JNCI J Natl Cancer Inst 100:277–281. https://doi.org/10.1093/jnci/djm291
Spier I, Holzapfel S, Altmüller J, Zhao B, Horpaopan S, Vogt S et al (2015) Frequency and phenotypic spectrum of germline mutations in POLE and seven other polymerase genes in 266 patients with colorectal adenomas and carcinomas. Int J Cancer 137:320–331. https://doi.org/10.1002/ijc.29396
Staal FJT, van der Luijt RB, Baert MRM, van Drunen J, van Bakel H, Peters E et al (2002) A novel germline mutation of PTEN associated with brain tumours of multiple lineages. Br J Cancer 86:1586–1591. https://doi.org/10.1038/sj.bjc.6600206
Stamos JL, Weis WI (2013) The β-Catenin destruction complex. Cold Spring Harb Perspect Biol 5:a007898. https://doi.org/10.1101/cshperspect.a007898
Tabori U, Shlien A, Baskin B, Levitt S, Ray P, Alon N et al (2010) TP53 alterations determine clinical subgroups and survival of patients with choroid plexus tumors. J Clin Oncol 28:1995–2001. https://doi.org/10.1200/JCO.2009.26.8169
Taylor MD, Northcott PA, Korshunov A, Remke M, Cho Y-J, Clifford SC et al (2012) Molecular subgroups of medulloblastoma: the current consensus. Acta Neuropathol (Berl) 123:465–472. https://doi.org/10.1007/s00401-011-0922-z
Therkildsen C, Ladelund S, Rambech E, Persson A, Petersen A, Nilbert M (2015) Glioblastomas, astrocytomas and oligodendrogliomas linked to Lynch syndrome. Eur J Neurol 22:717–724. https://doi.org/10.1111/ene.12647
Tighe A, Johnson VL, Taylor SS (2004) Truncating APC mutations have dominant effects on proliferation, spindle checkpoint control, survival and chromosome stability. J Cell Sci 117:6339–6353. https://doi.org/10.1242/jcs.01556
Turcot J, Despres JP, St Pierre F (1959) Malignant tumors of the central nervous system associated with familial polyposis of the colon: report of two cases. Dis Colon Rectum 2:465–468
Tutlewska K, Lubinski J, Kurzawski G (2013) Germline deletions in the EPCAM gene as a cause of Lynch syndrome—literature review. Hered Cancer Clin Pract 11:9. https://doi.org/10.1186/1897-4287-11-9
Varley JM, McGown G, Thorncroft M, Santibanez-Koref MF, Kelsey AM, Tricker KJ et al (1997) Germ-line mutations of TP53 in Li–Fraumeni families: an extended study of 39 families. Cancer Res 57:3245–3252
Vasen HFA, Ghorbanoghli Z, Bourdeaut F, Cabaret O, Caron O, Duval A et al (2014) Guidelines for surveillance of individuals with constitutional mismatch repair-deficiency proposed by the European Consortium “Care for CMMR-D” (C4CMMR-D). J Med Genet 51:283–293. https://doi.org/10.1136/jmedgenet-2013-102238
Vasen HFA, Tomlinson I, Castells A (2015) Clinical management of hereditary colorectal cancer syndromes. Nat Rev Gastroenterol Hepatol 12:88–97. https://doi.org/10.1038/nrgastro.2014.229
Villani A, Shore A, Wasserman JD, Stephens D, Kim RH, Druker H et al (2016) Biochemical and imaging surveillance in germline TP53 mutation carriers with Li–Fraumeni syndrome: 11 year follow-up of a prospective observational study. Lancet Oncol 17:1295–1305. https://doi.org/10.1016/S1470-2045(16)30249-2
Vital A, Bringuier P-P, Huang H, San-Galli F, Rivel J, Ansoborlo S et al (1998) Astrocytomas and choroid plexus tumors in two families with identical p53 germline mutations. J Neuropathol Exp Neurol 57:1061–1069. https://doi.org/10.1097/00005072-199811000-00009
Watson P, Vasen HFA, Mecklin J-P, Bernstein I, Aarnio M, Järvinen HJ et al (2008) The risk of extra-colonic, extra-endometrial cancer in the Lynch syndrome. Int J Cancer 123:444–449. https://doi.org/10.1002/ijc.23508
Wimmer K, Beilken A, Nustede R, Ripperger T, Lamottke B, Ure B et al (2017) A novel germline POLE mutation causes an early onset cancer prone syndrome mimicking constitutional mismatch repair deficiency. Fam Cancer 16:67–71. https://doi.org/10.1007/s10689-016-9925-1
Wimmer K, Kratz CP, Vasen HFA, Caron O, Colas C, Entz-Werle N et al (2014) Diagnostic criteria for constitutional mismatch repair deficiency syndrome: suggestions of the European consortium “care for CMMRD” (C4CMMRD). J Med Genet 51:355–365. https://doi.org/10.1136/jmedgenet-2014-102284
Wong P, Verselis SJ, Garber JE, Schneider K, DiGianni L, Stockwell DH et al (2006) Prevalence of early onset colorectal cancer in 397 patients with classic Li–Fraumeni syndrome. Gastroenterology 130:73–79. https://doi.org/10.1053/j.gastro.2005.10.014
Yakubov E, Ghoochani A, Buslei R, Buchfelder M, Eyüpoglu IY, Savaskan N (2016) Hidden association of Cowden syndrome, PTEN mutation and meningioma frequency. Oncoscience 3:149–155. https://doi.org/10.18632/oncoscience.305
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Kim, B., Tabori, U. & Hawkins, C. An update on the CNS manifestations of brain tumor polyposis syndromes. Acta Neuropathol 139, 703–715 (2020). https://doi.org/10.1007/s00401-020-02124-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00401-020-02124-y